Sources

9 Total Sources

FDA Approves Lipfendra Pill, Cutting LDL Cholesterol by Up to 60%

FDA Approves Oral PCSK9 Inhibitor Lipfendra (Enlicitide) for Cholesterol

The Star Online7d ago

FDA Approves New Daily Pill Lipfendra for Lowering Dangerous Cholesterol

Medical News Today8d ago

FDA Approves Lipfrenda (Enlicitide) on July 16, 2026, for LDL Cholesterol Reduction

Tech Times8d ago

New Cholesterol Rules Add 21.5 Million Americans to Statin Eligibility List

NorthcentralPA.com9d ago

FDA Approves Lipfendra, First Oral PCSK9 Inhibitor for High LDL Cholesterol

New York Post 8d ago

FDA signs off on Merck's cholesterol-lowering pill

minutebrief.in8d ago

US FDA Approved First Pill (Lipfendra) Replacing Injections for High Cholesterol | MinuteBrief

Yahoo! Voices8d ago

FDA approves 1st-of-its-kind pill to reduce cholesterol

The Spokesman Review9d ago

FDA Approves Lipfendra Daily Pill for High Cholesterol Treatment